BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 21388622)

  • 1. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial.
    Dai YL; Luk TH; Yiu KH; Wang M; Yip PM; Lee SW; Li SW; Tam S; Fong B; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2011 Jun; 216(2):395-401. PubMed ID: 21388622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
    Chan YH; Lau KK; Yiu KH; Li SW; Chan HT; Fong DY; Tam S; Lau CP; Tse HF
    Eur Heart J; 2008 Nov; 29(22):2800-7. PubMed ID: 18812325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.
    Tiano L; Belardinelli R; Carnevali P; Principi F; Seddaiu G; Littarru GP
    Eur Heart J; 2007 Sep; 28(18):2249-55. PubMed ID: 17644511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
    Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
    Hamilton SJ; Chew GT; Watts GF
    Diabetes Care; 2009 May; 32(5):810-2. PubMed ID: 19228872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 and exercise training in chronic heart failure.
    Belardinelli R; Muçaj A; Lacalaprice F; Solenghi M; Seddaiu G; Principi F; Tiano L; Littarru GP
    Eur Heart J; 2006 Nov; 27(22):2675-81. PubMed ID: 16882678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial.
    Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Fong B; Wong WK; Tam S; Lau CP; Tse HF
    Eur J Prev Cardiol; 2012 Aug; 19(4):830-9. PubMed ID: 21724681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
    Lee BJ; Huang YC; Chen SJ; Lin PT
    Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.
    Lee BJ; Huang YC; Chen SJ; Lin PT
    Nutrition; 2012 Jul; 28(7-8):767-72. PubMed ID: 22342390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
    Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G
    Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.
    Safarinejad MR
    Int J Impot Res; 2010; 22(5):298-309. PubMed ID: 20720560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sodium and potassium supplementation on endothelial function: a fully controlled dietary intervention study.
    Gijsbers L; Dower JI; Schalkwijk CG; Kusters YH; Bakker SJ; Hollman PC; Geleijnse JM
    Br J Nutr; 2015 Nov; 114(9):1419-26. PubMed ID: 26343780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
    Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.
    Enseleit F; Sudano I; Périat D; Winnik S; Wolfrum M; Flammer AJ; Fröhlich GM; Kaiser P; Hirt A; Haile SR; Krasniqi N; Matter CM; Uhlenhut K; Högger P; Neidhart M; Lüscher TF; Ruschitzka F; Noll G
    Eur Heart J; 2012 Jul; 33(13):1589-97. PubMed ID: 22240497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers.
    Kato T; Inoue T; Morooka T; Yoshimoto N; Node K
    Can J Physiol Pharmacol; 2006 May; 84(5):523-9. PubMed ID: 16902597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease.
    Dai YL; Luk TH; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Tam S; Fong B; Lau CP; Tse HF
    Cardiovasc Toxicol; 2010 Jun; 10(2):130-8. PubMed ID: 20383667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.